Took profits today.Hoping to have another go a few months down the track. Too much uncertainty, $3 mill cash burn for qtr , cap raising around the cnr?.Not shifting enough units.FDA approval would be a boost and sales to china could surprise.
Printable View
Haven't checked right back.Is anyone in VLA Viralytics VLA?.Cancer, melanoma etc. Heres a few research reports Roth have a $3.84 target ,s/p 79c atm. A couple of friends hold.
Eye-Catching MITCI Data
Viralytics’ Cavatak Delivers Benefits In Combination With Checkpoint Inhibitors
CAVATAK Plugging Away on All Fronts; Nice CALM and MITCI Updates
MITCI Results Show Promise
I've been in for about a year - taking a small position on the first leg up from memory and adding a few more in the SPP. It was very much a punt though since I'm not familiar with the field and have recently re-balanced. That aside, they have a solid cash position, the recent news results/news flow seems to have been well-received and you have to love the price targets floating round
.
http://www.asx.com.au/asx/research/company.do#!/OPT
OPT - OPTHEA: Positive news today from first human trial, jumped 10% :)
Good one.New one on me OPT and at a 1 year high.Missed your post DH.
I have done nothing for a while.The stocks i traded are a in the dumps last i looked so glad i left in the black.Only holding NRT deep in the red and getting a bit stale on it. Sa la vie. Glad some can still mine the biotech successfully. Anyone else doing well on anything in what isa depressed sector as i see it ,generally.?
Cheers JT. Like several health related stocks - hold PGC and LHC, and seriously looking at SDI - see http://www.capitalhmanagement.com.au...07/26/sdi-ltd/
But only hold OPT in biotech - c'est tout :)
Here's an interesting take on Australian life sciences stocks.
http://www.ndfresearch.com/the-comin...-sciences.html
Thanks macduffy. A coming boom in life sciences (Bio?)stocks ; i hope so. the thing is whats the easiest way to pick the sector taking off. I hope to start a thread about identifying and sharing a sector that takes off like the M/S did recently for great gains if one picked up on it early.
Two great announcements by NRT today. Im still deep in the red atm. but this looks redeeming; thinking longer term as one needs to with BIO's .DYOR
Dr James Garner presentation to Rodman & Renshaw conference-NRT.AX
FDA approves IND application for Cantrixil-NRT.AX
Does anyone else hold OPTHEA? Up a further 18% today, with latest trial results well received by "retina professionals".
http://www.marketwired.com/press-rel...xy-2157305.htm
The share price has risen steadily to have quadrupled in 12 months :)
Beautifully simple business model - unique but complementary therapy for the leading cause of blindness - ie not competing with existing drugs but enhancing their effectiveness.